# SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations

> **NCT00406588** · PHASE3 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 295 (actual)

## Conditions studied

- Advanced Stage Parkinson's Disease

## Interventions

- **DRUG:** Levodopa (Pardoprunox)
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT00406588
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-04
- **Final completion:** 2008-05
- **Target enrollment:** 295 (ACTUAL)
- **Last updated:** 2015-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00406588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00406588, "SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00406588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*